The Royal Pharmaceutical Society (RPS) has published a new GB-wise policy on independent prescribing.
It maintains that greater use of pharmacist independent prescribers (PIPs) will increase patient access to medicines and support, and believes all pharmacists in direct patient care roles should have access to independent prescriber training.
Key recommendations in the new policy document on independent prescribing include:
· New models of care should enable PIPs to routinely use their skills and knowledge to benefit patient care
· A clear pathway must be developed for pharmacists to become qualified Independent Prescribers.
RPS President Ash Soni commented: “Pharmacists have a unique and in-depth education in all aspects of medicines and medicines use, essential to the safe monitoring, support and treatment of patients. PIPs must become part of the multidisciplinary team to improve health outcomes and help overcome some of the challenges in today’s NHS.
“Opportunities for PIPs are increasing due to innovations in the way health services are shaped and delivered. I can only see this trend increasing as we move towards more integrated care.
“We want to see these recommendations implemented to drive quality improvements in the delivery of care. More PIPs would also increase capacity in the system and reduce demand on primary care and acute and emergency services.”